rs375308440
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_022114.4(PRDM16):c.2449G>A(p.Gly817Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000119 in 1,549,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G817G) has been classified as Likely benign.
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000211 AC: 35AN: 166224Hom.: 0 AF XY: 0.000140 AC XY: 13AN XY: 92698
GnomAD4 exome AF: 0.0000730 AC: 102AN: 1397404Hom.: 0 Cov.: 36 AF XY: 0.0000653 AC XY: 45AN XY: 689546
GnomAD4 genome AF: 0.000538 AC: 82AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000483 AC XY: 36AN XY: 74506
ClinVar
Submissions by phenotype
Left ventricular noncompaction 8 Uncertain:1Benign:1
PRDM16 NM_022114.3 exon 9 p.Gly817Ser (c.2449G>A): This variant has not been reported in the literature but is present in 0.2% (41/18334) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-3329210-G-A). This variant is present in ClinVar (Variation ID:241425). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Gly817Ser var iant in PRDM16 has not been previously reported in individuals with cardiomyopat hy, but has been identified in 0.2% (6/2466) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs375308440 ). Computational prediction tools and conservation analysis suggest that the p.G ly817Ser variant may impact the protein, though this information is not predicti ve enough to determine pathogenicity. In summary, while the clinical significanc e of the p.Gly817Ser variant is uncertain, its frequency suggests that it is mor e likely to be benign. -
PRDM16-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
This variant is associated with the following publications: (PMID: 30847666) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at